By HotStockRockets | Saturday 21 February 2015
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
OptiBiotix Health (OPTI) has announced the appointment of a Commercial Director – Jim Laird – who has worked in commercial and corporate roles for some of the world's leading food companies and should enable OptiBiotix to develop a wider range of product and partnering opportunities.
Laird has experience from Birds Eye (Unilever), Walkers Snacks (Pepsico), as General Manager of Quorn (the world's leading meat-free brand) and from an FMCG consultancy business to support companies with strategic and corporate development.
OptiBiotix emphasises that his “licensing, partnering, and acquisition experience brings food industry specific commercial and corporate expertise to OptiBiotix”.
With the company’s recent developments taking it to within spitting distance of commercalisation, this looks a further positive development – and the shares are up meaningfully to a current 22.75p-23.p in response.
Still expecting further positive newsflow in the near-term though, we remain confident in our targeted 30p being reached shortly – and, whilst recommending extreme caution with broker reports, note that broker Hybridan is significantly more confident reckoning that the shares are worth 49p or maybe 200p, the note is a bit confusing but bullish none the less.
Strong hold (at worst)
Hot Stock Rockets will be serving up its next red hot tip - its share tip of the month- next week. To access the UK’s fastest growing share tipping website for less than £5 a month ( or for £5 for one month) click HERE
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |